| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SYNTA PHARMACEUTICALS CORP | 37,058,136 | 71,893,000 | 85.78% | ||
| 2 | CELATOR PHARMACEUTICALS INC | 2,246,469 | 5,549,000 | 6.62% | ||
| 3 | AMERICAN CAP LIMITED | 65,055 | 962,000 | 1.15% | ||
| 4 | ESTERLINE TECHNOLOGIES CORP COM | 7,107 | 813,000 | 0.97% | ||
| 5 | SENSATA TECHNOLOGIES HLDNG PLC SHS | 10,634 | 611,000 | 0.73% | ||
| 6 | SPDR SER TR | 2,532 | 571,000 | 0.68% | Put | |
| 7 | RELYPSA INC | 11,210 | 405,000 | 0.48% | ||
| 8 | PIONEER FLOATING RATE TR | 32,874 | 382,000 | 0.46% | ||
| 9 | Esperion Therapeutics Inc | 3,671 | 340,000 | 0.41% | ||
| 10 | PROSPECT CAPITAL CORPORATION | 36,527 | 309,000 | 0.37% | ||
| 11 | MEDLEY MGMT INC | 27,760 | 305,000 | 0.36% | ||
| 12 | EATON VANCE SR INCOME TR | 45,659 | 297,000 | 0.35% | ||
| 13 | MEDLEY CAP CORPORATION | 31,961 | 292,000 | 0.35% | ||
| 14 | Agile Therapeutics, Inc. | 26,736 | 248,000 | 0.30% | ||
| 15 | BLACKSTONE GSO LNG SHRT CR I | 13,909 | 224,000 | 0.27% | ||
| 16 | NUVEEN SR INCOME FD | 29,777 | 198,000 | 0.24% | ||
| 17 | TICC CAPITAL CORP | 23,742 | 164,000 | 0.20% | ||
| 18 | BLACKROCK FLOATING RATE INCO | 10,958 | 152,000 | 0.18% | ||
| 19 | ACELRX PHARMACEUTICALS INC | 21,870 | 84,000 | 0.10% | ||
| 20 | REGADO BIOSCIENCES INC | 11,327 | 14,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-004270, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
